
Patients with cancer develop serious bacterial infections often, especially during periods of severe and prolonged zzso zzso usage for the prevention and treatment of bacterial infections in these high-risk patients leads to selection pressures resulting in the emergence and spread of resistant zzso Many organisms acquire several resistance mechanisms, making them zzso zzso zzso as resistance to three or more different classes of zzso These infections are associated with increased zzso mortality and zzso The development of novel zzso agents with activity against pathogens that have become resistant to currently available agents is one strategy for combating resistant zzso Several novel agents have either recently been approved, or are in various stages of development and are discussed in zzso It is unlikely that these agents will have a major impact on reducing the development and spread of zzso zzso zzso the judicious use of currently available agents referred to as zzso zzso and the development of and adherence to appropriate zzso Control policies and procedures are vital components in the management of these high-risk zzso 

